Molecular Radionuclidepharmacy Private Limited, a active private limited company, was established on 13 March 2014 in Ernakulam, Kerala, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U73100KL2014PTC036408. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Mibu Jose (Director), Kizhakkebhagathu Ajith Joy (Managing Director), Smitha Ajith (Director). Past directors included Mibu Jose, Smitha Ajith, Mathew Francis Kattukkaran. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Xix/326, Kizhakkebhagathu Gardens Puthiyakavu, Thripunithura P.O, Ernakulam, Kerala, 682301.
U73100KL2014PTC036408
036408
13 March 2014
₹1.00 M
₹1.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Molecular Radionuclidepharmacy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mibu Jose | Director | 10 Jan 2024 | Current |
| Kizhakkebhagathu Ajith Joy | Managing Director | 13 Mar 2014 | Current |
| Smitha Ajith | Director | 26 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 13 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 26 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Molecular Radionuclidepharmacy Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 2980.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Molecular Radionuclidepharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Molecular Radionuclidepharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Molecular Radionuclidepharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Radionuclidepharmacy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Molecular Radionuclidepharmacy Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Molecular Radionuclidepharmacy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
Progress on Mibu Jose was appointed as a Director was appointed as a Director on 10 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
Progress on Smitha Ajith was appointed as a Director was appointed as a Director on 26 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
Progress on Kizhakkebhagathu Ajith Joy was appointed as a Managing Director was appointed as a Managing Director on 13 Mar 2014 & has been associated with this company since 11 years 8 months . was documented.
The activity Molecular Radionuclidepharmacy Private Limited was registered on 13 Mar 2014 with Roc Ernakulam & aged 11 years 8 months as per MCA records. was completed.
The CIN of Molecular Radionuclidepharmacy Private Limited is U73100KL2014PTC036408.
Molecular Radionuclidepharmacy Private Limited is headquartered at Xix/326, Kizhakkebhagathu Gardens Puthiyakavu, Thripunithura P.O, Ernakulam, Kerala, 682301.
Molecular Radionuclidepharmacy Private Limited was incorporated on 13 March 2014.
The current directors of Molecular Radionuclidepharmacy Private Limited are
The primary industry of Molecular Radionuclidepharmacy Private Limited is Hospital And Medical Care.
Molecular Radionuclidepharmacy Private Limited is unlisted.
The authorized capital of Molecular Radionuclidepharmacy Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Molecular Radionuclidepharmacy Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX